share_log

Allarity Therapeutics Has Received A Decision To Grant European Patent Number EP3794149 Titled "METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS".

Benzinga ·  Sep 27 03:59
Allarity Therapeutics Has Received A Decision To Grant European Patent Number EP3794149 Titled "METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS".
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment